Hong Kong surges 2.1% as China eases COVID rules; mainland markets mixed

Hong Kong's stock market opened Wednesday morning with a sharp upward move, climbing 2.1% as traders digested China's sweeping decision to dismantle most of its COVID restrictions and begin reopening its borders to the world. The timing mattered: Hong Kong had been closed for Christmas, and investors were playing catch-up with a major policy shift that signaled the end of an era of strict containment.

The mainland markets told a more complicated story. China's blue-chip CSI 300 Index edged down 0.2% by mid-morning, while the Shanghai Composite Index barely moved. Hong Kong, by contrast, surged. The Hang Seng China Enterprises Index—which tracks major Chinese companies listed in Hong Kong—jumped 2.6%. The divergence reflected genuine uncertainty about what reopening would mean in practice.

China's announcement was substantial: starting January 8, the government would stop requiring travelers entering the country to quarantine. This represented a fundamental shift in posture after years of zero-COVID policies that had isolated the nation economically and socially. But the timing revealed a tension at the heart of the moment. Even as officials announced the easing, Chinese hospitals were buckling under a surge of infections. The country was moving toward treating COVID as endemic—a disease to live with rather than eliminate—precisely as cases were climbing sharply, straining medical resources across the system.

Goldman Sachs analysts framed the policy shift as "a major step towards the full reopening," but added a caveat: the near term would bring "increased challenges to China's medical system." The market's reaction reflected this mixed outlook. Technology companies listed in Hong Kong surged 2.7%, riding momentum from their U.S.-listed counterparts, which had jumped overnight. The Nasdaq Golden Dragon China index, tracking Chinese tech stocks on Wall Street, added 2.1%. But automobiles slumped 2.5%, suggesting traders were hedging their bets on which sectors would benefit from reopening and which might face headwinds.

Banks rose 1.3%, a sign that financial institutions stood to gain from renewed economic activity. Yet UBS Securities' Chief Investment Office warned that surging case numbers had stoked fresh anxiety about economic recovery, and the firm expected more volatility ahead as markets tried to price in competing scenarios.

Analysts offered a timeline for what might come next. The first wave of infections was expected to peak around mid-January, then level off after the Spring Festival in early February. If that pattern held, consumption—the engine of China's economy—could begin a gradual rebound starting in the first or second quarter of 2023. For now, though, the market was caught between the promise of reopening and the immediate reality of a healthcare system under strain, with investors unsure which force would dominate in the weeks ahead.